PUBLISHER: KBV Research | PRODUCT CODE: 1220127
PUBLISHER: KBV Research | PRODUCT CODE: 1220127
The Latin America, Middle East and Africa Veterinary Orthopedic Implants Market would witness market growth of 7.5% CAGR during the forecast period (2022-2028).
The rising incidence of orthopaedic problems, such as injuries and arthritis, in animals is the primary factor fueling the expansion of the veterinary orthopaedic implants market. Consequently, this emphasises the need for veterinary orthopaedic implants in the field of orthopaedic medicine. There has also been a rise in the number of reported instances of canine cruciate ligament rupture.
The availability of better animal healthcare infrastructure, the rise in unmet animal healthcare demands, and the surge in demand for veterinary orthopaedics implants are all factors that are likely to fuel the growth of the veterinary orthopaedic implants market in unexplored, emerging regions. In addition, the development of cutting-edge surgical methods to treat the illness is seen as an opportunity for market growth throughout the forecast period. It's not just in the developed world where demand is rising for veterinary orthopaedic implants.
Brazil is a potential country in the regional pet food industry due to its high levels of pet ownership, increasing concern for pet health, and increased expenditure on natural, high-quality pet care. Small families, childless couples, and single people in Brazil's densely populated cities often keep fish and birds in addition to dogs and cats as pets because the country has the most varied pet population in the world. Also, many major companies are moving into the region to take advantage of the booming economy there. It is anticipated that these companies would introduce new, ground-breaking items at competitive prices to meet the market's unfulfilled needs. As a result of all this, the market is predicted to expand in the LAMEA region.
The Brazil market dominated the LAMEA Veterinary Orthopedic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,365.6 Thousands by 2028. The Argentina market is experiencing a CAGR of 8.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.2% during (2022 - 2028).
Based on End User, the market is segmented into Hospital, Clinics, and Others. Based on Product Type, the market is segmented into Plates, Screws, and Others. Based on Application, the market is segmented into Cruciate Ligament Rupture, Bone Fractures, Hip Dysplasia, Elbow Dysplasia, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.
Market Segments covered in the Report:
By End User
By Product Type
By Application
By Country
Companies Profiled
Unique Offerings from KBV Research
List of Figures